Beta Drugs Limited

Web: betadrugslimited.com NSE: BETA SECTOR: Healthcare - Pharmaceuticals & Biotechnology

2297 18(-1%)

Near 52W High of 2424

Volume

80k as on 23, Jun

Open

High

Low

2,315

VWAP

2,132

52 Week High

2,424

52 Week Low

990

Viand Research Rating

Quality Score

53/100

Growth Score

13/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,393

No. of Shares

1.01

P/E

P/B

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

ROCE

Profit Growth

Listing Date

12-Oct-17

Promoter Holding

59.1%

FII Holding

1.02%

DII Holding

6.23%

Price Chart

Price Performance

1 Week11%

1 Month52%

3 Months96%

6 Months87%

1 Year87%

YTD87%

Moving Average

5 Day SMA2,010

10 Day SMA1,853

20 Day SMA1,649

30 Day SMA1,535

50 Day SMA1,458

61 Day SMA1,429

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	2,348	2,182	2,299	2,337
Resistance 2	2,299	2,170	2,251	2,294
Resistance 1	2,223	2,159	2,222	2,212
Pivot Point	2,174	2,148	2,174	2,169
Support 1	2,098	2,136	2,126	2,088
Support 2	2,049	2,125	2,097	2,044
Support 3	1,974	2,113	2,049	1,963

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(-5.51) 59.10%	(-0.31) 64.63%	(-1.81) 64.90%	(0.01) 66.73%	(0.01) 66.73%	(0.01) 66.73%	(0.01) 66.73%	(0.01) 66.73%	(0.01) 66.73%	(0.01) 66.73%	(0.01) 66.73%	(0.01) 66.73%	(0.01) 66.73%	(0.01) 66.73%	(0.01) 66.71%	(0.01) 66.71%	(0.01) 66.71%	(0.01) 66.71%	(0.01) 66.71%	(0.01) 66.68%
FIIs	(-0.11) 1.02%	(0.01) 1.16%	(0.21) 1.14%	(0.01) 0.90%	(0.01) 0.90%	(-0.31) 0.90%	(0.01) 1.15%	(0.31) 1.16%	(0.61) 0.90%	(0.01) 0.32%	(0.01) 0.32%	(0.01) 0.32%	(0.01) 0.29%	(0.01) 0.29%	(0.01) 0.29%	(0.31) 0.29%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(4.11) 6.23%	(0.31) 2.15%	(1.61) 1.90%	(0.01) 0.29%	(0.11) 0.26%	(0.01) 0.17%	(0.01) 0.17%	(0.01) 0.16%	(0.11) 0.12%	(0.01) 0.06%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.04%	(0.01) 0.04%	(0.01) 0.04%	(-0.31) 0.04%	(0.01) 0.29%	(0.01) 0.29%	(0.01) 0.29%	(0.01) 0.28%
Public	33.65%	32.06%	32.07%	32.07%	32.11%	32.20%	31.95%	31.95%	32.25%	32.87%	32.92%	32.93%	32.93%	32.94%	32.96%	32.96%	33.00%	33.00%	33.01%	33.03%
No. of Shareholders	7,359	4,736	3,694	3,184	3,139	3,054	2,882	2,567	2,323	2,116	1,928	1,722	1,451	1,424	1,444	1,407	1,296	762	675	542

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Mar 2024	Sep 2023	Mar 2023	Sep 2022	Mar 2022	Sep 2021	Mar 2021	Sep 2020	Mar 2020	Sep 2019
Sales	126	94	87	103	100	94	88	180	154	141	115	112	96	88	65	51	44	47
Sales Growth % (YoY)	25.3%	0.2%	-1.2%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales Growth % (QoQ)	34%	8%	-15.5%	3%	6.4%	6.8%	-51.1%	16.9%	9.2%	22.6%	2.7%	16.7%	9.1%	35.4%	27.5%	15.9%	-6.4%	-
Expenses	98	76	70	82	81	76	70	141	127	108	88	86	73	68	51	41	36	37
Operating Profit	27	18	17	21	20	17	18	39	27	33	26	27	23	20	14	11	8	9
OPM %	22	19	19	21	20	18	21	22	18	23	23	24	24	23	22	21	19	20
Other Income	2	3	2	3	3	2	-1	2	1	1	0	0	0	0	0	0	0	0
Interest	3	4	4	4	3	3	2	2	1	1	1	1	1	1	1	1	2	1
Depreciation	4	5	4	4	4	4	3	6	4	5	6	5	4	3	4	3	2	2
Profit before tax	22	12	10	16	16	12	12	33	22	27	20	21	18	16	9	7	5	7
Tax %	25	24	19	26	25	26	25	25	25	25	25	25	27	28	30	21	14	27
Net Profit	16	9	9	12	12	9	9	24	17	20	15	16	13	12	7	5	4	5
Net Profit Growth % (QoQ)	77.8%	-	-25%	-	33.3%	-	-62.5%	41.2%	-15%	33.3%	-6.2%	23.1%	8.3%	71.4%	40%	25%	-20%	-
Net Profit Growth % (YoY)	33.3%	-	-	-50%	-	-47.1%	-	20%	13.3%	25%	15.4%	33.3%	85.7%	140%	75%	-	-	-
TTM Net Profit	46	42	42	42	54	42	50	41	37	35	31	29	25	19	12	9	9	0
EPS in Rs	15.59	8.93	8.4	12.11	11.59	8.95	8.86	24.2	16.4	19.67	14.73	15.67	12.95	11.63	6.48	5.13	4.25	5.07

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Sales	385	362	296	227	184	116	91	66	51
Sales Growth %	6.2%	22.5%	30.2%	23.5%	58.3%	27.9%	37.7%	30.4%	-
Expenses	309	288	236	174	141	91	73	54	41
Operating Profit	76	75	60	53	43	25	18	12	9
OPM %	20	21	20	23	23	21	20	18	19
Other Income	11	2	1	1	1	0	0	0	0
Interest	15	7	3	2	2	2	3	1	1
Depreciation	17	13	10	10	7	7	4	3	2
Profit before tax	54	57	49	41	34	16	12	8	7
Tax %	24	26	25	25	28	27	21	-2	1
Net Profit	41	42	36	31	25	12	9	8	7
Net Profit Growth %	-2.4%	16.7%	16.1%	24%	108.3%	33.3%	12.5%	14.3%	-
EPS in Rs	40.92	42.02	36.08	30.42	24.58	11.6	9.33	8.84	7.43
Dividend Payout %	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Cash from Operating Activity	37	36	31	23	30	19	8	0	17
Cash from Investing Activity	-51	-36	-14	-19	-22	-6	-15	-21	-11
Cash from Financing Activity	-8	118	-7	-2	-1	-8	9	12	5
Net Cash Flow	-22	118	9	2	7	5	2	-9	12

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Equity Capital	10	10	10	10	10	10	10	10	10	9	9
Reserves	235	211	187	171	148	113	83	59	48	32	24
Borrowings	148	146	138	19	15	20	21	17	23	20	8
Other Liabilities	103	121	101	95	82	55	45	31	28	22	9
Total Liabilities	496	488	436	295	254	198	158	118	107	83	50
Fixed Assets	125	112	89	66	65	63	55	40	44	18	13
CWIP	0	0	0	0	0	0	0	3	0	15	1
Investments	0	0	0	0	0	1	1	1	0	0	0
Other Assets	371	376	347	229	190	135	102	74	63	50	35
Total Assets	496	488	436	295	254	198	158	118	107	83	50

Delivery

#	Date	1171 128% 2674	Value (Cr)	Q/T 12	Del 44	Del 10
1	22-Jul	2315	15	7	47	7
2	21-Jul	2478	13	8	28	3
3	20-Jul	2439	130	10	14	19
4	17-Jul	2229	10	5	30	3
5	16-Jul	2261	3	6	60	2
6	15-Jul	2305	4	7	37	2
7	14-Jul	2310	5	6	38	2
8	13-Jul	2348	12	8	40	5
9	10-Jul	2367	22	8	36	8
10	9-Jul	2190	19	8	34	6
11	8-Jul	1998	5	6	49	2
12	7-Jul	2069	3	6	52	2
13	6-Jul	2153	5	7	35	2
14	3-Jul	2090	8	10	51	4
15	2-Jul	2156	2	6	50	1
16	1-Jul	2185	4	6	44	2
17	30-Jun	2185	6	9	35	2
18	29-Jun	2163	9	10	39	3
19	25-Jun	2097	3	10	40	1
20	24-Jun	2164	7	9	39	3
21	23-Jun	2093	17	11	46	8
22	22-Jun	2148	27	15	30	8
23	19-Jun	1990	4	11	51	2
24	18-Jun	1948	12	13	42	5
25	17-Jun	1872	7	13	40	3
26	16-Jun	1890	13	14	38	5
27	15-Jun	1836	40	15	17	7
28	12-Jun	1771	31	18	33	10
29	11-Jun	1476	1	8	42	1
30	10-Jun	1503	1	7	41	1
31	9-Jun	1523	3	9	53	1
32	8-Jun	1430	1	8	58	1
33	5-Jun	1467	1	13	64	1
34	4-Jun	1472	1	9	52	1
35	3-Jun	1454	2	10	41	1
36	2-Jun	1416	2	9	73	1
37	1-Jun	1423	3	15	65	2
38	29-May	1430	3	6	61	2
39	27-May	1442	2	9	57	1
40	26-May	1400	4	9	44	2
41	25-May	1369	5	16	57	3
42	22-May	1377	11	15	41	5
43	21-May	1237	1	14	65	1
44	20-May	1215	3	11	44	1
45	19-May	1192	3	17	69	2
46	18-May	1216	4	13	55	2
47	15-May	1272	8	10	47	4
48	14-May	1404	2	7	59	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	2,393c	16c	0.67
22-Jul	2,409c	174c	6.73
21-Jul	2,583c	332c	14.75
17-Jul	2,251c	88c	3.75
16-Jul	2,339c	2c	0.08
15-Jul	2,341c	14c	0.59
14-Jul	2,327c	82c	3.41
13-Jul	2,409c	50c	2.12
10-Jul	2,359c	137c	6.17
09-Jul	2,222c	201c	9.93
08-Jul	2,021c	94c	4.45
07-Jul	2,116c	46c	2.12
06-Jul	2,161c	32c	1.48
02-Jul	2,194c	31c	1.41
01-Jul	2,225c	3c	0.14
30-Jun	2,228c	40c	1.84
29-Jun	2,188c	90c	4.27
26-Jun	2,098c	63c	2.92
25-Jun	2,161c	44c	1.98
24-Jun	2,205c	67c	3.13
23-Jun	2,138c	52c	2.36
22-Jun	2,190c	172c	8.54
19-Jun	2,017c	125c	6.59
17-Jun	1,893c	6c	0.32
16-Jun	1,887c	45c	2.42
15-Jun	1,842c	46c	2.59
12-Jun	1,795c	284c	18.80
11-Jun	1,511c	30c	1.97
10-Jun	1,542c	0	0

Stock Checklist

Price is above from 52 week high low average: 82%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

NseIndia | Trendlyne | Screener | TradingView